Orbital angular momentum of light

WiMi Developed Metasurface Eyepiece for Augmented Reality with Ultra-wide FOV

Retrieved on: 
Friday, September 8, 2023
Cloud, Holography, Pressure, Augmented reality, WIMI, Eye, NA, Orbital angular momentum of light, Research, Temperature, Transmittance, Ultra, Mobility, FOV, Glass, AR, Telescopic sight

BEIJING, Sept. 8, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that a metasurface eyepiece for augmented reality has been developed, which is based on metasurfaces composed of artificially fabricated subwavelength structures.

Key Points: 
  • BEIJING, Sept. 8, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that a metasurface eyepiece for augmented reality has been developed, which is based on metasurfaces composed of artificially fabricated subwavelength structures.
  • A metasurface eyepiece developed by WiMi for augmented reality underwent a series of optical performance tests to ensure that it has high transmittance, modulation efficiency and dispersion characteristics.
  • The technology has the following differences and advantages over the current technology and it can address some of the problems and defects of the current technology:
    Ultra-wide FOV: The metasurface eyepiece achieves an ultra-wide FOV relative to traditional augmented reality glasses.
  • This innovation will drive the industry forward and provide users with a more immersive and high-quality augmented reality experience.

LEADOPTIK Receives Investment from Applied Ventures

Retrieved on: 
Tuesday, June 20, 2023
Hair, Surgeon, Travel, Biopsy, Cancer, Orbital angular momentum of light, Needle, Applied Materials, Lung, Venture, SOSV, Silicon, SAN, Engineering, Principal, YP, ENEA, FDA, Medical imaging

SAN JOSE, Calif., June 20, 2023 /PRNewswire/ -- LEADOPTIK Inc., a Silicon Valley-based medical imaging company today announced that it has secured venture capital funding from Applied Ventures, LLC. This new injection of capital augments a recently announced $5 million over-subscribed seed venture funding round led by MetaVC Partners with participation from SOSV, Sony Innovation Fund, TSVC, ENEA, and others. This will allow LEADOPTIK to move to the next stage of product development, including FDA approval, on the path to commercialization.

Key Points: 
  • SAN JOSE, Calif., June 20, 2023 /PRNewswire/ -- LEADOPTIK Inc. , a Silicon Valley-based medical imaging company today announced that it has secured venture capital funding from Applied Ventures , LLC.
  • This will allow LEADOPTIK to move to the next stage of product development, including FDA approval, on the path to commercialization.
  • "We are excited to be an investor in LEADOPTIK," said Yuan-Ping (YP) Huang, Principal of Applied Ventures, the venture capital arm of Applied Materials, Inc. "We see metamaterials, particularly optical metasurfaces and flat optics based on materials engineering capabilities, enabling a new wave of innovative products that can be smaller, faster, and less costly than traditional optics."
  • "Applied Ventures is an outstanding deep-tech investor and technology advisor for us," stated Reza Khorasaninejad, Founder and CEO of LEADOPTIK.

LEADOPTIK Raises $5 Million in Series Seed Funding to Advance Early Lung Cancer Detection with Cutting-Edge Imaging Technology

Retrieved on: 
Monday, May 22, 2023
Hair, Surgeon, Travel, Biopsy, Survival, Cancer, Lung cancer, Orbital angular momentum of light, BioWare, Needle, SOSV, Silicon, Patient, SAN, Diagnosis, ENEA, FDA, World Health Organization, Medical imaging, Dropbox

LEADOPTIK is developing a miniaturized imaging system ushering in a new level of real-time imaging deep inside human lungs and enabling early diagnoses of cancer.

Key Points: 
  • LEADOPTIK is developing a miniaturized imaging system ushering in a new level of real-time imaging deep inside human lungs and enabling early diagnoses of cancer.
  • According to the World Health Organization, lung cancer is responsible for the highest number of cancer-related deaths worldwide.
  • Early detection and diagnosis are vital to a patient's survival; however, there are currently no effective approaches for diagnosing cancer at its earliest stages.
  • "The work that LEADOPTIK is doing in developing novel imaging technologies to address lung cancer detection is a perfect example of that."

LATYS Secures $3 Million in Seed Round Led by Rhapsody Venture Partners

Retrieved on: 
Monday, February 6, 2023
Technology, Mobile, Wireless, Engineering, Manufacturing, Transport, Telecommunications, IOT (Internet of Things), Networks, Internet, Hardware, Other Manufacturing, Logistics, Supply Chain Management, Satellite, VoIP, Internet of things, General partnership, Rhapsody, Hertz, Orbital angular momentum of light, Cable television, Wi-Fi

LATYS, a startup delivering a drop-in antenna that extends wireless signals without interference, announced its $3 million seed financing from hard tech investor Rhapsody Venture Partners (Rhapsody) with participation from existing investor, TandemLaunch Ventures.

Key Points: 
  • LATYS, a startup delivering a drop-in antenna that extends wireless signals without interference, announced its $3 million seed financing from hard tech investor Rhapsody Venture Partners (Rhapsody) with participation from existing investor, TandemLaunch Ventures.
  • LATYS’ technology is signal agonistic and expected to find broad adoption in 5G, IoT, Wi-Fi, and Industry 4.0.
  • LATYS’ unique antenna technology utilizes a metasurface to repeat wireless signals, without any processing by passively focusing the signal.
  • LATYS’ antennas blew us away, because they took a completely different approach,” said Bernard Lupien, General Partner at Rhapsody.